Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
+2.93% | -1.82% |
02-02 | Novozymes, Chr. Hansen Complete Merger Settlement | MT |
02-02 | Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Nordic All-Share Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- Based on current prices, the company has particularly high valuation levels.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.82% | 10.38B | - | ||
-7.09% | 26.97B | B- | ||
+18.44% | 24.49B | B | ||
+11.07% | 11.31B | B- | ||
+6.91% | 4.01B | B+ | ||
-18.99% | 3.37B | C | ||
-5.61% | 3.12B | B+ | ||
+29.20% | 2.8B | C+ | ||
-16.19% | 2.49B | C+ | ||
-14.66% | 1.95B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- CHR Stock
- 51C Stock
- Ratings Christian Hansen